Age-Adjusted Survival Extrapolations—Results May Differ From Those Generated by the Weibull Model
Author:
Affiliation:
1. HTA Unit, Regione Toscana and ESTAR, Regional Health Service, Firenze, Italy
2. Hospital Pharmacy Department, Bolzano Central Hospital, Bolzano, Italy
3. Scientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milan, Italy
Publisher
American Medical Association (AMA)
Subject
Cardiology and Cardiovascular Medicine
Link
https://jamanetwork.com/journals/jamacardiology/articlepdf/2789703/jamacardiology_messori_2022_le_210028_1651705089.44119.pdf
Reference5 articles.
1. Dapagliflozin in patients with heart failure and reduced ejection fraction.;McMurray;N Engl J Med,2019
2. Extrapolating long-term event-free and overall survival with dapagliflozin in patients with heart failure and reduced ejection fraction: an exploratory analysis of a phase 3 randomized clinical trial.;Docherty;JAMA Cardiol,2021
3. Estimating the lifetime benefits of treatments for heart failure.;Ferreira;JACC Heart Fail,2020
4. The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long-term studies.;Messori;ESC Heart Fail,2021
5. Messori? A. Weibull extrapolation of survival data: analysis of 36 articles published in PubMed. Open Science Framework. Preprint posted online July 31, 2021. Accessed August 2, 2021. https://osf.io/3bh48/
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3